Browse funders

…Introduction The U.S. Food and Drug Administration (FDA) investigated the potential risk of suicidal ideation and behav…

…Background A critical evaluation of the US Food and Drug Administration (FDA) recommendation to avoid intracranial stent placement (ICA…

…lantation genetic testing requiredFood and Drug administration (FDA) requirements to cryopreserve reproductive tissueConsent for st…

…edications regarding impurities and adverse effects.224–228 The FDA considers the use of compounded obesity medications as risky, a…

…a (alone or in combination with ipilimumab (IPI)). In 2022, the FDA approved a fixed-dose combination of NIVO plus relatlimab (NIVO…

… used to justify regulatory approval of a new medication by the FDA. However, clinical trials may not be designed around patient-ce…

…ns in the control of cancerous cells. CAR-T therapy is a recent FDA approved treatment which utilizes T-cells engineered to express…

…In the past three decades, the US Food and Drug Administration (FDA) has increasingly relied on surrogate endpoints (eg, disease-fr…

…mary suspect. Duplicate entries were removed using standardised FDA protocols. Adverse events (AEs) were categorised using the Medi…

…ne MCED test has received the ‘Breakthrough’ designation by the FDA, which allows for surrogate markers as primary endpoints. These…

…than 97% of readings fell within the no-risk zone; however, the FDA’s iCGM criteria for non-adjunctive use were not met.Conclusions…

…tment has been approved by the US Food and Drug Administration (FDA).…